In rabbit hearts with hypertrophy and HF induced by pressure/volume overload, two-month NHE1 inhibitor treatment reduced duration of action potential QT-interval and QRS, restored sodium and calcium handling and alleviated the incidence of calcium after-transients, as well as hypertrophy and HF [74]. This evidence concerns the gene SLC9A1 and cardiac hypertrophy.